TENORMIN

This brand name is authorized in United States. It is also authorized in Australia, Austria, Canada, Cyprus, Ecuador, Germany, Hong Kong SAR China, Italy, Japan, Malta, Mexico, Nigeria, Singapore, South Africa, Spain, UK.

Active ingredients

The drug TENORMIN contains one active pharmaceutical ingredient (API):

1	Atenolol UNII 50VV3VW0TI - ATENOLOL
	Atenolol is a beta-blocker which is beta1-selective, (i.e. acts preferentially on beta1-adrenergic receptors in the heart). Atenolol is without intrinsic sympathomimetic and membrane-stabilising activities and as with other beta-blockers, has negative inotropic effects.
	Read more about Atenolol

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
TENORMIN Solution for injection	MPI, EU: SmPC	Medicines & Healthcare Products Regulatory Agency (GB)
TENORMIN Tablets	MPI, EU: SmPC	Medicines & Healthcare Products Regulatory Agency (GB)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
C07AB03	Atenolol	C Cardiovascular system → C07 Beta blocking agents → C07A Beta blocking agents → C07AB Beta blocking agents, selective
Discover more medicines within C07AB03

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
AU	Pharmaceutical Benefits Scheme	1081X
CA	Health Products and Food Branch	02039532, 02039540
DE	Bundesinstitut für Arzneimittel und Medizinprodukte	02477686
EC	Agencia Nacional de Regulación, Control y Vigilancia Sanitaria	361630812, 362951112
ES	Centro de información online de medicamentos de la AEMPS	56777, 56967
GB	Medicines & Healthcare Products Regulatory Agency	13308, 27862
HK	Department of Health Drug Office	06812, 17873
IT	Agenzia del Farmaco	024016038
JP	医薬品医療機器総合機構	2123011F1155, 2123011F2437
MT	Medicines Authority	AA565/41701
MX	Comisión Federal para la Protección contra Riesgos Sanitarios	88870
NG	Registered Drug Product Database	04-0336
SG	Health Sciences Authority	00348P, 08669P
US	FDA, National Drug Code	52427-429, 52427-430, 52427-431
ZA	Health Products Regulatory Authority	27/5.2/0251, J/5.2/0120, P/5.2/174, P/5.2/268